SCHEMBL24920898

SCHEMBL24920898

COc1nccc(-c2ncno2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.39
CCR1 P32246 1/20 0.35
CCR5 P51681 1/20 0.35
CCR8 P51685 1/20 0.35
MAPK14 Q16539 5/20 0.34
MAPK13 O15264 3/20 0.34
MAPK12 P53778 3/20 0.34
MAPK11 Q15759 3/20 0.34
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A1 P04798 1/20 0.33
CYP2E1 P05181 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C8 P10632 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP4B1 P13584 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24921235 0.77 CCR1 (0.61) CCR1CCR5CCR8CYP1A2CYP2D6
SCHEMBL14031549 0.76 PDPK1 (0.40) PDPK1CCR1CCR5CCR8MAPK14
SCHEMBL24920894 0.75 ACHE (0.40) PDPK1CCR1CCR5CCR8MAPK14
SCHEMBL24921238 0.73 BTK (0.42) MAPTPDE10AKDM4ENPC1RAB9A
SCHEMBL24920772 0.72 NOTUM (0.45) PDPK1CCR1CCR5CCR8PIM1
SCHEMBL24920893 0.72 PTGDR (0.45) PDPK1CCR1CCR5CCR8MAPK14
SCHEMBL24921964 0.71 PDE10A (0.31) PDE10A
SCHEMBL24920890 0.70 PDPK1 (0.39) PDPK1CCR1CCR5CCR8MAPK14
SCHEMBL24920803 0.70 S1PR1 (0.35) PIM1PIM2CYP1A2CYP2D6CYP2C9
SCHEMBL24921972 0.69 MAOB (0.35) MAPTPDE10AKDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed